TECH BUYER Feb 2021 - IDC Perspective - Doc # EUR146580021

European Life Sciences Key IT Deals and Initiatives Update, Q4 2020

By: Nino GiguashviliSenior Research Analyst


This IDC Market Perspective provides IDC Health Insights' review of key IT deals, news, and digital initiatives in European life sciences and pharma in Q4 2020. In the unfolding COVID-19 scenario, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments to promptly spot favorable opportunities and remain competitive in the market during the crisis and beyond. This is the 10th in the quarterly series of reports IDC Health Insights has released as it continues to provide in-depth research coverage of the life sciences markets across Europe.

"In the last quarter of 2020, European life sciences firms continued investments in digital solutions to speed up drug discovery and enable virtual trials, while accelerating efforts to enable supply chain operations for COVID-19 vaccination preparedness. The quarter saw a growing number of tech vendors launch solutions to support an efficient and equitable rollout of COVID-19 vaccines. The rollout presents enormous complexities at all levels, including unparalleled scale, delivery timelines, and cold-chain requirements." — Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe



Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.

Related Links

Do you have questions about this document
or available subscriptions?

Contact Us